338 PHARMACOLOGICAL AND GENETIC EVIDENCE SUPPORTING THE POTENTIAL USEFULNESS OF BLOCKING SIGMA‐1 RECEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN | Publicación